As of February 19 2026 a new clinical trial entry highlights a standardised stabilisation exercise protocol for volleyball players with non traumatic shoulder instability. The change is the formal documenting of an exercise based regimen to address shoulder stability in athletes. Clinicians, trainers and regulatory teams should monitor the trial as it progresses. The trial, titled Effectiveness of a Standardised Stabilisation Exercise Protocol in Volleyball Players With Non traumatic Shoulder Instability, uses an exercise based intervention. The sponsor listed is Universidad Francisco de Vitoria. The record shows the status not yet recruiting and is registered on ClinicalTrials.gov under NCT07400900 with a reference to the term medical device. Access to the source record is provided via the link below. Intended audience includes clinicians, physiotherapists, sports medicine professionals and regulatory teams who track trial activity and safety data in athletes with shoulder instability. In this article: What change does this trial describe? Who is affected? What are the regulatory implications?
What change does this trial describe?
The trial evaluates a standardised stabilisation exercise protocol for volleyball players dealing with non traumatic shoulder instability. The intervention is exercise. The sponsor is Universidad Francisco de Vitoria. The record shows the status not yet recruiting. This article summarizes the trial’s scope for regulatory and clinical audiences.
What is the intervention?
The intervention is a standardised stabilisation exercise protocol designed to improve shoulder control and stability in athletes with instability not caused by trauma. The regimen is exercise based and delivered under supervision as part of standard rehabilitation practices.
Who sponsors and registers the trial?
Sponsored by Universidad Francisco de Vitoria, the trial is registered on ClinicalTrials.gov under NCT07400900. The entry notes the intervention type and the condition studied.
What is the population and setting?
The target population includes volleyball players with non traumatic shoulder instability. The exact age range and inclusion criteria are not detailed in the available record, but the setting involves sport clinical environments.
Who should care about this trial?
Clinicians in sports medicine and physical therapy will find this trial relevant as it focuses on a stabilisation programme for the shoulder. Athletic trainers, coaching staff and regulatory professionals may monitor the trial for safety, design transparency and potential future device and protocol standardisations.
What are the regulatory implications for this trial?
The record follows standard clinical trial reporting practices and provides information on sponsor, intervention type and status. Because the intervention is an exercise protocol rather than a device, the MDR related implications focus on compliance with trial registration and safety reporting rather than device classification. Manufacturers statements are not included in the record. The information supports risk management and post market surveillance planning for future deployment of stabilisation protocols in athletic populations.
FAQ
- 1. What is the aim of the trial?
To assess the effectiveness of a standardised stabilisation exercise protocol for volleyball players with non traumatic shoulder instability.
- 2. Who sponsors the trial?
Universidad Francisco de Vitoria.
- 3. Where can I find the trial record?
ClinicalTrials.gov NCT07400900 link provided below.
Conclusion
In review, the trial description communicates a clear aim to generate evidence on a stabilisation exercise approach for shoulder stability in athletes. The status not yet recruiting indicates that results are not yet available for practice guidance. Stakeholders should monitor the record for updates and ensure alignment with regulatory reporting standards prior to any broader use of the protocol.
Disclaimer
This article is intended for professional audiences and does not constitute legal or regulatory advice. It reflects information from a trial record and does not replace official MDR guidance or regulatory communications.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07400900?term=medical+device